<DOC>
	<DOCNO>NCT02543879</DOCNO>
	<brief_summary>This open-label , multicenter , dose-escalation Phase 1 study patient acute leukemia/high-risk MDS non-Hodgkin Lymphoma , intend investigate safety , pharmacokinetics , pharmacodynamic effect FT-1101 administer via one intermittent dose schedule . Once MTD establish , 56 additional patient may enrol 4 expansion cohort select patient population recommend dose future study confirm safety .</brief_summary>
	<brief_title>Study Novel BET Inhibitor FT-1101 Patients With Relapsed Refractory Hematologic Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<criteria>Key Histologically cytologically proven acute leukemia highrisk MDS define World Health Organization ( WHO ) criterion IPSSR , respectively , relapse refractory standard therapy standard treatment contraindicate , OR Mature BCell nonHodgkin Lymphoma Relapsed/Refractory standard therapy Patients â‰¥ 18 year old Good kidney liver function No prior organ allograft For fertile men woman , agreement use effective contraceptive method duration study participation 90 day Key History prior malignancy unless disease free &gt; 2 year . Patients symptomatic central nervous system ( CNS ) metastases tumor location ( spinal cord compression , compressive mass , uncontrolled painful lesion , bone fracture , etc . ) necessitate urgent therapeutic intervention , palliative care , surgery radiation therapy Treatment major surgery ( require general anesthesia ) within one month prior study entry Previous treatment prior BET inhibitor therapy Patients unable swallow oral medication , patient gastrointestinal condition ( e.g . malabsorption , gastric small bowel resection , etc . ) deem jeopardize intestinal absorption Congestive heart failure ( New York Heart Association Class III IV ) unstable angina pectoris . Previous history myocardial infarction within 1 year prior study entry , uncontrolled hypertension uncontrolled arrhythmias Pulmonary disease ( e.g . COPD , asthma , etc ) control ( moderate severe symptom ) current medication Known HIV positivity Active , uncontrolled bacterial , viral , fungal infection , require systemic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>AML</keyword>
	<keyword>BET Inhibitor</keyword>
	<keyword>FT-1101</keyword>
	<keyword>Acute Leukemia</keyword>
	<keyword>Myelodysplastic Syndrome</keyword>
</DOC>